Effects of curcumin on hypoxia-inducible factor as a new therapeutic target

Afsane Bahrami, Stephen Atkin, Muhammed Majeed, Amirhossein Sahebkar

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that consists of two subunits, the HIF-1α and HIF-1β (ARNT). Under hypoxic conditions, HIF-1 is an adaptive system that regulates the transcription of multiple genes associated with growth, angiogenesis, proliferation, glucose transport, metabolism, pH regulation and cell death. However, aberrant HIF-1 activation contributes to the pathophysiology of several human diseases such as cancer, ischemic cardiovascular disorders, and pulmonary and kidney diseases. A growing body of evidence indicates that curcumin, a natural bioactive compound of turmeric root, significantly targets both HIF-1 subunits, but is more potent against HIF-1α. In this review, we have summarized the knowledge about the pharmacological effects of curcumin on HIF-1 and the related molecular mechanisms that may be effective candidates for the development of multi-targeted therapy for several human diseases.

Original languageEnglish
Pages (from-to)159-169
Number of pages11
JournalPharmacological Research
Volume137
DOIs
Publication statusPublished - 1 Nov 2018

Fingerprint

Hypoxia-Inducible Factor 1
Curcumin
Therapeutics
Curcuma
Hypoxia
Kidney Diseases
Lung Diseases
Cell Death
Transcription Factors
Pharmacology
Glucose

Keywords

  • Aryl hydrocarbon receptor nuclear translocator
  • Hypoxia-responsive elements
  • Turmeric
  • Von Hippel-Lindau

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. / Bahrami, Afsane; Atkin, Stephen; Majeed, Muhammed; Sahebkar, Amirhossein.

In: Pharmacological Research, Vol. 137, 01.11.2018, p. 159-169.

Research output: Contribution to journalReview article

Bahrami, Afsane ; Atkin, Stephen ; Majeed, Muhammed ; Sahebkar, Amirhossein. / Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. In: Pharmacological Research. 2018 ; Vol. 137. pp. 159-169.
@article{189f984d7504464db4b1aa36c5804d00,
title = "Effects of curcumin on hypoxia-inducible factor as a new therapeutic target",
abstract = "Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that consists of two subunits, the HIF-1α and HIF-1β (ARNT). Under hypoxic conditions, HIF-1 is an adaptive system that regulates the transcription of multiple genes associated with growth, angiogenesis, proliferation, glucose transport, metabolism, pH regulation and cell death. However, aberrant HIF-1 activation contributes to the pathophysiology of several human diseases such as cancer, ischemic cardiovascular disorders, and pulmonary and kidney diseases. A growing body of evidence indicates that curcumin, a natural bioactive compound of turmeric root, significantly targets both HIF-1 subunits, but is more potent against HIF-1α. In this review, we have summarized the knowledge about the pharmacological effects of curcumin on HIF-1 and the related molecular mechanisms that may be effective candidates for the development of multi-targeted therapy for several human diseases.",
keywords = "Aryl hydrocarbon receptor nuclear translocator, Hypoxia-responsive elements, Turmeric, Von Hippel-Lindau",
author = "Afsane Bahrami and Stephen Atkin and Muhammed Majeed and Amirhossein Sahebkar",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.phrs.2018.10.009",
language = "English",
volume = "137",
pages = "159--169",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Effects of curcumin on hypoxia-inducible factor as a new therapeutic target

AU - Bahrami, Afsane

AU - Atkin, Stephen

AU - Majeed, Muhammed

AU - Sahebkar, Amirhossein

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that consists of two subunits, the HIF-1α and HIF-1β (ARNT). Under hypoxic conditions, HIF-1 is an adaptive system that regulates the transcription of multiple genes associated with growth, angiogenesis, proliferation, glucose transport, metabolism, pH regulation and cell death. However, aberrant HIF-1 activation contributes to the pathophysiology of several human diseases such as cancer, ischemic cardiovascular disorders, and pulmonary and kidney diseases. A growing body of evidence indicates that curcumin, a natural bioactive compound of turmeric root, significantly targets both HIF-1 subunits, but is more potent against HIF-1α. In this review, we have summarized the knowledge about the pharmacological effects of curcumin on HIF-1 and the related molecular mechanisms that may be effective candidates for the development of multi-targeted therapy for several human diseases.

AB - Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that consists of two subunits, the HIF-1α and HIF-1β (ARNT). Under hypoxic conditions, HIF-1 is an adaptive system that regulates the transcription of multiple genes associated with growth, angiogenesis, proliferation, glucose transport, metabolism, pH regulation and cell death. However, aberrant HIF-1 activation contributes to the pathophysiology of several human diseases such as cancer, ischemic cardiovascular disorders, and pulmonary and kidney diseases. A growing body of evidence indicates that curcumin, a natural bioactive compound of turmeric root, significantly targets both HIF-1 subunits, but is more potent against HIF-1α. In this review, we have summarized the knowledge about the pharmacological effects of curcumin on HIF-1 and the related molecular mechanisms that may be effective candidates for the development of multi-targeted therapy for several human diseases.

KW - Aryl hydrocarbon receptor nuclear translocator

KW - Hypoxia-responsive elements

KW - Turmeric

KW - Von Hippel-Lindau

UR - http://www.scopus.com/inward/record.url?scp=85054851741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054851741&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2018.10.009

DO - 10.1016/j.phrs.2018.10.009

M3 - Review article

VL - 137

SP - 159

EP - 169

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -